CERVICAL SCREENING FOR GENITOURINARY SYNDROME OF MENOPAUSE

Download full text PDF
Issue: 
8
Year: 
2017

Professor T. Klinyshkova (1), MD; I. Samosudova (2), Candidate of Medical Sciences, O. Mironova (3) 1-Omsk State Medical University 2-Ultramed Clinical and Diagnostic Center, Omsk 3-Clinical Diagnostic Center, Omsk

The cervical cytological and colposcopic characteristics depending on the phase of the climacteric (peri- and postmenopausal) period, which have been established in the comprehensive examination of patients with genitourinary syndrome of menopause, justify the use of local estrogen therapy.
Keywords: 
gynecology
genitourinary syndrome of menopause
perimenopause
postmenopause
cervix uteri
colposcopy
liquid-based cytology

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Portman D., Gass M. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society // Maturitas. – 2014; 79 (3): 349–54.
  2. Apolihina I.A., Gorbunova E.A. Kliniko-morfologicheskie aspekty vul'vovaginal'noj atrofii // Med. sovet. – 2014; 9: 110–7.
  3. Kim H., Kang S., Chung Y. et al. The Recent Review of the Genitourinary Syndrome of Menopause // J. Menopausal. Med. – 2015; 21 (2): 65–71.
  4. Goldstein I., Dicks B., Kim N. et al. Multidisciplinary Overview of Vaginal Atrophy and Associated Genitourinary Symptoms in Postmenopausal Women // Sex Med. – 2013; 1 (2): 44–53.
  5. Parish S., Nappi R., Krychman M. et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy // Int. J. Womens Health. – 2013; 5: 437–47.
  6. DiBonaventura M., Luo X., Moffatt M. et al. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe // J. Womens Health (Larchmt). – 2015; 24 (9): 713–22.
  7. Kingsberg S., Kellogg S., Krychman M. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy // Int. J. Womens Health. – 2009; 1: 105–11.
  8. Klinyshkova T.V., Samosudova I.B., Mironova O.N. Otsenka tservikal'nogo skrininga pri lechenii vul'vovaginal'noj atrofii v peri- i postmenopauze // Ginekologija. – 2016; 6: 32–5.
  9. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy // Climacteric. – 2016; 19: 109–50.
  10. Menopauzal'naja gormonoterapija i sohranenie zdorov'ja zhenschin zrelogo vozrasta. Klinicheskie rekomendatsii. Pod red. L.V. Adamjan, V.N. Serova, G.T. Suhih, O.S. Filippova // Problemy reproduktsii (spets. vyp.). – 2015; 6 (21): 451–9.